Evidence map›Paper›PMID 26893509›Full record

ArticlePhysical therapy2016

Dietary Protein Intake and Lean Muscle Mass in Survivors of Childhood Acute Lymphoblastic Leukemia: Report From the St. Jude Lifetime Cohort Study.

Alexandra M Boland, Todd M Gibson, Lu Lu, Sue C Kaste, James P DeLany, Robyn E Partin, Jennifer Q Lanctot, Carrie R Howell, Heather H Nelson, Wassim Chemaitilly and 5 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Physical therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00137111 (Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00137111 phase3completednot on this map

Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia

TypeinterventionalSponsorSt. Jude Children's Research HospitalRan2000 to 2014Enrolled501ConditionsLymphoblastic Leukemia, AcuteArmsPrednisone, Dexamethasone, Vincristine, Daunorubicin, Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginase, Methotrexate, Cyclophosphamide, Cytarabine, Etoposide, Mercaptopurine, Imatinib, chemotherapy, intrathecal chemotherapy
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Skeletal muscle health in childhood cancer survivors: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Alexandra M BolandA.M. Boland, MPH, School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Todd M GibsonT.M. Gibson, PhD, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.
Lu LuL. Lu, MS, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital.
Sue C KasteS.C. Kaste, DO, Department of Diagnostic Imaging, St. Jude Children's Research Hospital; Department of Oncology, St. Jude Children's Research Hospital; and Department of Radiology, University of Tennessee School of Health Sciences, Memphis, Tennessee.
James P DeLanyJ.P. DeLany, PhD, Division of Endocrinology and Metabolism, University of Pittsburgh, Pittsburgh, Pennsylvania.
Robyn E PartinR.E. Partin, MS, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital.
Jennifer Q LanctotJ.Q. Lanctot, PhD, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital.
Carrie R HowellC.R. Howell, PhD, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital.
Heather H NelsonH.H. Nelson, PhD, School of Public Health, University of Minnesota.
Wassim ChemaitillyW. Chemaitilly, MD, Department of Endocrinology, St. Jude Children's Research Hospital.
Ching-Hon PuiC-H. Pui, MD, Department of Oncology, St. Jude Children's Research Hospital.
Leslie L RobisonL.L. Robison, PhD, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital.
Daniel A MulrooneyD.A. Mulrooney, MD, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, and Department of Oncology, St. Jude Children's Research Hospital.
Melissa M HudsonM.M. Hudson, MD, Department of Oncology, St. Jude Children's Research Hospital.
Kirsten K NessK.K. Ness, PT, PhD, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105-3678 (USA). kiri.ness@stjude.org.
University of Tennessee Health Science Center · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
The St. Jude Lifetime CohortU01CA195547 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI HUDSON, MELISSA M, NESS, KIRSTEN KIMBERLIE · 2015 to 2024
$14.9M
PROFESSIONAL ONCOLOGY EDUCATION PROGRAMR25CA023944 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SUZANNE A. GRONEMEYER · 1986 to 2026
$8.3M
Motor Proficiency and Physical Activity in Adult Survivors of Childhood ALLR01CA132901 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI NESS, KIRSTEN KIMBERLIE · 2009 to 2012
$2.6M
NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA132901NCI NIH HHS R25 CA023944NCI NIH HHS U01 CA195547
6 · The paper itself

Abstract

backgroundSurvivors of childhood acute lymphoblastic leukemia (ALL) are at risk for low lean muscle mass and muscle weakness, which may contribute to inactivity and early development of chronic diseases typically seen in older adults. Although increasing protein intake, in combination with resistance training, improves lean muscle mass in other populations, it is not known whether muscular tissue among survivors of ALL, whose impairments are treatment-related, will respond similarly.

objectiveThe aim of this study was to evaluate associations among dietary protein intake, resistance training, and lean muscle mass in survivors of ALL and age-, sex-, and race-matched controls.

designThis was a cross-sectional study.

methodsLean muscle mass was determined with dual-energy x-ray absorptiometry, dietary information with 24-hour recalls, and participation in resistance training with a questionnaire. Participants were 365 survivors of ALL (52% male; 87% white; median age=28.5 years, range=23.6-31.7) and 365 controls with no previous cancer.

resultsCompared with controls, survivors of ALL had lower lean muscle mass (55.0 versus 57.2 kg, respectively) and lower percentage of lean muscle mass (68.6% versus 71.4%, respectively) than controls. Similar proportions of survivors (71.1%) and controls (69.7%) met recommended dietary protein intake (0.8 g/kg/d). Survivors (45.4%) were less likely to report resistance training than controls (53.8%). In adjusted models, 1-g higher protein intake per kilogram of body mass per day was associated with a 7.9% increase and resistance training ≥1×wk, with a 2.8% increase in lean muscle mass. LIMITATIONS: The cross-sectional study design limits temporal evaluation of the association between protein intake and lean muscle mass.

conclusionsThe findings suggest that survivors of childhood ALL with low lean muscle mass may benefit from optimizing dietary protein intake in combination with resistance training. Research is needed to determine whether resistance training with protein supplementation improves lean muscle mass in survivors of childhood ALL.

Indexed as

Absorptiometry, PhotonAdolescentAdultBody CompositionCase-Control StudiesChildChild, PreschoolCross-Sectional StudiesDietary ProteinsFemaleHumansInfantMaleMiddle AgedMuscle, SkeletalMuscle WeaknessDietary Proteins

Identifiers

PMID26893509
PMCPMC4935785
OpenAlexW2318101855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.